1477 — Ocumension Therapeutics Share News
0.000.00%
Last trade - 00:00- HK$3.71bn
- HK$3.43bn
- CNY804.35m
Brief: Ocumension Therapeutics To Place 28 Mln Existing Shares At Placing Price Of Hk$28.35/Share
Brief: Ocumension Therapeutics Says Eyepoint Agreed To Issue 3 Mln Shares For US$15.7 Mln
Brief: Ocumension Therapeutics Says Ot-401 (Yutiq) Approved For Real World Study In China
Brief: Ocumension Therapeutics Initiation Of Second Phase 3 Clinical Trial Of OT-301 In U.S.
Brief: Nicox Initiates Second Phase 3 Trial Of NCX 470 In Glaucoma
Brief: Ocumension Therapeutics Says Unit Entered Collaboration & Exclusive Promotion Deal With Shandong Boan Biotechnology
Brief: Ocumension Therapeutics Says Phase III Clinical Trial Of Ot-301 (NCX 470) Approved In China
Brief: Ocumension Therapeutics Says Phase III Clinical Trial Of Ot-1001 (Zerviate) Approved In China
Brief: Ocumension Therapeutics Approves Acquisition Of Suzhou Xiaxiang
Brief: Ocumension Therapeutics Says HY Loss And Total Comprehensive Expenses RMB 1.74 Bln
Hong Kong speculators should read China Literature
Hong Kong's mom-and-pop investors squeeze funds as IPOs sizzle (updated)
Hong Kong's mom-and-pop investors squeeze funds as IPOs sizzle (updated)
Hong Kong's mom-and-pop investors squeeze funds as IPO sizzle
E-cigarette maker Smoore, Ocumension more than double on HK debut, others jump